Dimensional Fund Advisors’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,779
Closed -$18.6K 3252
2025
Q4
$18.6K Sell
2,779
-46,835
-94% -$278K ﹤0.01% 3235
2025
Q3
$218K Sell
49,614
-63,011
-56% -$299K ﹤0.01% 3109
2025
Q2
$500K Sell
112,625
-31,156
-22% -$130K ﹤0.01% 2993
2025
Q1
$814K Sell
143,781
-22,730
-14% -$291K ﹤0.01% 2916
2024
Q4
$3.51M Sell
166,511
-5,077
-3% -$117K ﹤0.01% 2636
2024
Q3
$4.62M Sell
171,588
-11,177
-6% -$329K ﹤0.01% 2536
2024
Q2
$5.21M Sell
182,765
-9,868
-5% -$346K ﹤0.01% 2480
2024
Q1
$8.17M Buy
192,633
+69
+0% +$3.1K ﹤0.01% 2396
2023
Q4
$10.3M Sell
192,564
-833
-0.4% -$37.6K ﹤0.01% 2309
2023
Q3
$8.32M Buy
193,397
+11,634
+6% +$537K ﹤0.01% 2351
2023
Q2
$9.98M Buy
181,763
+7,250
+4% +$398K ﹤0.01% 2259
2023
Q1
$7.33M Buy
174,513
+398
+0.2% +$11.8K ﹤0.01% 2348
2022
Q4
$4.82K Sell
174,115
-127
-0.1% -$3.13K ﹤0.01% 2471
2022
Q3
$4.46M Sell
174,242
-13,542
-7% -$448K ﹤0.01% 2467
2022
Q2
$6.76M Sell
187,784
-21
-0% -$948 ﹤0.01% 2351
2022
Q1
$11.7M Sell
187,805
-555
-0.3% -$32.8K ﹤0.01% 2226
2021
Q4
$13.3M Sell
188,360
-8,222
-4% -$585K ﹤0.01% 2194
2021
Q3
$13.7M Buy
196,582
+1,029
+0.5% +$81.9K ﹤0.01% 2180
2021
Q2
$16.3M Sell
195,553
-1,939
-1% -$137K 0.01% 2141
2021
Q1
$10.8M Sell
197,492
-5,207
-3% -$253K ﹤0.01% 2296
2020
Q4
$8.7M Sell
202,699
-7,408
-4% -$276K ﹤0.01% 2338
2020
Q3
$6.32M Sell
210,107
-6,585
-3% -$221K ﹤0.01% 2381
2020
Q2
$6.72M Buy
216,692
+895
+0.4% +$24.1K ﹤0.01% 2362
2020
Q1
$4.77M Buy
215,797
+2,517
+1% +$68.2K ﹤0.01% 2425
2019
Q4
$6.5M Buy
213,280
+743
+0.3% +$21.4K ﹤0.01% 2519
2019
Q3
$6.54M Buy
212,537
+662
+0.3% +$16.5K ﹤0.01% 2508
2019
Q2
$4.24M Buy
211,875
+7,102
+3% +$208K ﹤0.01% 2691
2019
Q1
$8.83M Buy
204,773
+6,064
+3% +$220K ﹤0.01% 2448
2018
Q4
$6.32M Buy
198,709
+306
+0.2% +$12.1K ﹤0.01% 2525
2018
Q3
$10.4M Buy
198,403
+4,609
+2% +$259K ﹤0.01% 2423
2018
Q2
$10.4M Buy
193,794
+7,080
+4% +$363K ﹤0.01% 2406
2018
Q1
$9.34M Buy
186,714
+10,197
+6% +$457K ﹤0.01% 2402
2017
Q4
$5.83M Buy
176,517
+2,438
+1% +$82.3K ﹤0.01% 2565
2017
Q3
$6.53M Buy
174,079
+3,007
+2% +$89K ﹤0.01% 2515
2017
Q2
$4.36M Buy
171,072
+7,937
+5% +$196K ﹤0.01% 2630
2017
Q1
$4.24M Buy
163,135
+2,050
+1% +$59.1K ﹤0.01% 2628
2016
Q4
$4.91M Buy
161,085
+160
+0.1% +$4.07K ﹤0.01% 2547
2016
Q3
$4.38M Sell
160,925
-45
-0% -$1.25K ﹤0.01% 2561
2016
Q2
$4.6M Buy
160,970
+1,419
+0.9% +$45.1K ﹤0.01% 2525
2016
Q1
$4.82M Sell
159,551
-1,109
-0.7% -$31.4K ﹤0.01% 2503
2015
Q4
$5.58M Sell
160,660
-1,437
-0.9% -$49.1K ﹤0.01% 2468
2015
Q3
$6.13M Buy
162,097
+5,695
+4% +$265K ﹤0.01% 2424
2015
Q2
$8.91M Buy
156,402
+3,626
+2% +$206K 0.01% 2326
2015
Q1
$8.89M Buy
152,776
+923
+0.6% +$49.6K 0.01% 2296
2014
Q4
$8.61M Buy
151,853
+1,095
+0.7% +$52.2K 0.01% 2337
2014
Q3
$6.17M Sell
150,758
-1,336
-0.9% -$61.4K ﹤0.01% 2450
2014
Q2
$6.92M Buy
152,094
+1,445
+1% +$60.7K ﹤0.01% 2427
2014
Q1
$7.14M Sell
150,649
-180
-0.1% -$8.19K 0.01% 2392
2013
Q4
$7.09M Sell
150,829
-46,971
-24% -$2.05M 0.01% 2391
2013
Q3
$7.89M Sell
197,800
-140
-0.1% -$5.51K 0.01% 2278
2013
Q2
$7.1M Buy
+197,940
New +$7.58M 0.01% 2270

Other funds holding HBIO